Inventor · disambiguated record
Amy Damask
Also filed as: DAMASK AMY
3 granted patents·7 pending applications·0 citations·filing 2015–2025
46Inventor score
Top patents by PatentIndex Score
10 records- 0168US2024404627A1Systems and Methods for Correcting for Noise and Systemic Variations in Sequencing DataREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0263US12378557B2Treatment of sepsis with PCSK9 and LDLR modulatorsREGENERON PHARMA·Filed 2021·Granted Aug 5, 2025·0 cites·6 claims
- 0359US2023113866A1Methods Of Treating Clonal Hematopoiesis Of Indeterminate Potential (CHIP) With Lymphocyte Antigen 75 (LY75), Cluster Of Differentiation 164 (CD164), Or Poly(ADP-Ribose) Polymerase 1 (PARP1) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0457US12264366B2Genome-based methods for reducing cardiovascular riskREGENERON PHARMA·Filed 2020·Granted Apr 1, 2025·0 cites·7 claims
- 0556US2025257406A1Genome-Based Methods For Reducing Cardiovascular RiskREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0656US2023340598A1Association Of T Cell Leukemia/Lymphoma Protein 1A (TCL1A) With Clonal Hematopoiesis Of Indeterminate Potential (CHIP)REGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0751US2022177982A1Methods Of Identifying Subjects Having An Increased Risk Of Developing A Coronavirus Infection And Treatment ThereofREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 0850US2020178741A1Methods of selectively treating asthma using il-13 antagonistsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0930US2019082912A1Methods Of Selectively Treating Asthma Using IL-13 AntagonistsNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1026US10066267B2Methods of selectively treating asthma using IL-13 antagonistsDAMASK AMY·Filed 2015·Granted Sep 4, 2018·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Amy Damask files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →